Table 2 Digital health industry clinical indications across the health continuum.
From: A digital health industry cohort across the health continuum
Prevention | Detection | Treatment | Monitoring | Coordination | All | ||
|---|---|---|---|---|---|---|---|
n | 167 | 91 | 266 | 284 | 295 | 702 | |
Clinical indication | None | 62.9% | 18.7% | 33.1% | 39.8% | 54.2% | 46.2% |
Populations | 8.4% | 12.1% | 17.7% | 18.7% | 24.1% | 15.4% | |
Other | 5.4% | 24.2% | 19.2% | 12.3% | 8.8% | 11.7% | |
Neurologic | 10.8%† | 14.3% | 7.5% | 3.2% | 1.4% | 7.1%† | |
Mental health | 6.6% | 3.3% | 11.7%† | 8.8% | 6.4%† | 7.0% | |
Endocrine | 5.4% | 6.6% | 6.0% | 9.5% | 4.7% | 6.0% | |
Cardiovascular | 2.4% | 15.4%† | 3.4% | 9.9%† | 1.4% | 5.8% | |
Oncologic | 0.0% | 14.3% | 7.1% | 0.7% | 1.4% | 4.3% | |
Women’s health | 3.0% | 7.7% | 4.9% | 3.9% | 2.0% | 4.1% | |
Pulmonary | 0.0% | 1.1% | 0.8% | 2.8% | 1.0% | 1.4% |
